Trial and Appellate Victory for Kreg Therapeutics
Chapman Spingola LLP wins in the Seventh Circuit United States Court of Appeals, affirming seven figure trial result for client Kreg Therapeutics, Inc.
After U.S. District Judge Robert M. Dow summarily determined that defendant VitalGo, Inc. had breached the parties’ exclusive distribution agreement, Chapman Spingola LLP proved at trial that Kreg had suffered what is known under New York law as “lost-asset damages” and obtained for Kreg a total award in excess of $1 million.
Peter M. Spingola, Sara Siegall and John M. Owen tried the case, with Robert J. Shapiro and James P. Chapman assisting on the pre and post-trial briefing.
“For nearly fifteen years, I have turned to Chapman Spingola when the chips are down,” said Craig Poulos, President of Kreg Therapeutics .  “In this instance, the firm’s tenacity and trial experience helped Kreg recoup substantial monetary losses. I am very pleased with the trial team’s performance and the result.”
VitalGo appealed claiming that the result was flawed by an array of reversible errors both on summary judgment and at trial. Peter Spingola and Sara Siegall argued the appeal before Circuit Judges Diane Sykes, Amy Barrett and Amy St. Eve.  The Seventh Circuit issued a unanimous 23-page opinion affirming Judge Dow’s ruling . John Owen, Robert Shapiro and James Chapman assisted on the briefing.
“We are proud of this result as it once again demonstrates Chapman Spingola’s ability to win both at trial and on appeal when there is no business settlement to be had,” said firm co-founder Peter Spingola .